Infensa scientists publish in European Heart Journal showing efficacy of lead drug candidate when administered at relevant timepoints in preclinical models of moderate and severe myocardial infarction

Written by Guest User

Read more: Acid-sensing ion channel 1a blockade reduces myocardial injury in rodent models of myocardial infarction | European Heart Journal | Oxford Academic

Guest User
Previous

Brisbane startup Infensa spins medical miracle from spider venom
Next

Infensa CEO Mark Smythe received the LSQ McCullough Robertson Industry Excellence Award from Life Sciences Queensland in recognition of his major contributions to the Queensland life sciences industry